Chairman of the Board
Chang-Hai Tsai, Ph. D.
President and CEO
Jung Chin Lin, Ph. D. (hon)
Vice President, Product Development and Intellectual Property
David C. Chou, Ph. D.
Senior Director, Regulatory Affairs and Project Management
Senior Director, Clinical Development Division
Senior Director, New Drug Development Division
Director, New Drug Development Division
Shu-Hua Lee (Alice)
Director, Pre-Clinical Development Division
Sheng-Wen Yeh, Ph. D.